Spontaneous resolution of left bundle branch block and biventricular stimulation lead to reverse remodeling in dyssynchronopathy  by Kloosterman, Mariëlle et al.
Available online at www.sciencedirect.com
ScienceDirect
Journal of Electrocardiology 49 (2016) 696 – 698
www.jecgonline.comSpontaneous resolution of left bundle branch block and biventricular
stimulation lead to reverse remodeling in dyssynchronopathy☆
Mariëlle Kloosterman, BSc, Michiel Rienstra, MD, PhD, Isabelle C. Van Gelder, MD, PhD,
Alexander H. Maass, MD, PhD⁎
Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsAbstract Left bundle branch block (LBBB) is considered a marker of underlying structural cardiac disease. To☆ Disclosures: M
reports grants from N
grant 016.136.055), o
receiving grant suppor
Jude Medical. Dr. M
Boston Scientific, Me
⁎ Corresponding
University of Groning
30.001, 9700 RB, Gro
E-mail address:
http://dx.doi.org/10.10
0022-0736/© 2016 Thdetermine whether LBBB is cause or consequence of deterioration of left ventricular (LV) function is
difficult as both are often diagnosed concomitantly. We discuss a patient where reversal of LBBB
and subsequent normalization of LV function was observed after 2 different therapies, first after start
of heart failure medication, and years later after implantation of a cardiac resynchronization device.
This indicates that LBBB per se may result in the development of non-ischemic cardiomyopathy and
that LBBB resolution can lead to reverse remodeling in dyssynchronopathy.
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Left bundle branch block (LBBB) may occur in asymp-
tomatic individuals, patients with extensive myocardial
infarction, and in those with heart failure (HF), especially in
non-ischemic cardiomyopathies. It may even be the first
manifestation of heart disease whereas the clinical presentation
of a non-ischemic cardiomyopathy develops years later [1].
LBBB causes slow activation of left ventricular (LV) septum
and delayed activation of the lateral and basal walls of the LV
that can eventually lead to depressed left ventricular ejection
fraction (LVEF) [2]. Because LBBB itself can accelerate LV
dysfunction, LBBB and HF may have synergistic effects.
Determining whether LBBB or deterioration of LV function is
the trigger is often unclear as both are diagnosed concomitantly.
Case report
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e Authors. Published by Elsevier Inc. This is an open accessThe patient experienced no other complaints. The electrocardio-
gram (ECG) demonstrated sinus rhythm, 95 bpm, with complete
LBBB and QRS duration of 134 ms. No previous ECGs were
present. Laboratory findings were non-contributory. Chest
radiography and computed tomographic scan showed no hilar
and mediastinal lymphadenopathy, parenchymal changes, pul-
monary edema, pericardial thickening or pleural effusion.
Pulmonary function testing revealed a restrictive, impaired lung
volume, impaired diffusing capacity, and normal airway
resistance. Bronchoscopy showed no abnormalities. Echocardi-
ography showed dilatation of the LV and asynchronous
ventricular contraction. Echocardiographic data were as follows:
left ventricular end diastolic diameter (LVEDD) 67 mm; left
ventricular end systolic diameter (LVESD) 55 mm; interventric-
ular septal thickness 10 mm; and left ventricular poster wall
thickness 9 mm. No valve dysfunctions were observed. The
multigated acquisition scan (MUGA) showed severely compro-
misedLVfunctionwith aLVEFof23%. 99mTcMIBI scintigraphy
revealed diffusely reduced uptake of the myocardium, most
notably anterior, infero-apical and at the basal septal and inferior
wall. Coronary angiography showed no significant coronary artery
disease. Results were consistent with non-ischemic cardiomyop-
athy. The patient was started on standardHFmedication including
ACE-inhibitor, diuretic,β-blocker, carbasalate calcium, and begun
an individualized cardiac rehabilitation program.
He was seen regularly at the outpatient clinic and almost
immediately after starting medication his condition started to
rapidly improve. Within six months after medication initiationarticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. QRS duration (blue) and LVEF (red) changes from the moment of
presentation in 2003 until late 2015. After the start of HF medication QRS
duration rapidly decreased, only to increase again in 2007. LVEF closely
follows the changes in QRS duration, improving when QRS duration
decreases and deteriorating when QRS duration increases. After CRT
implantation in 2011 QRS duration and LVEF decreased and increased once
more respectively, then stabilized. *CRT denotes cardiac resynchronization
therapy; HF, heart failure; LVEF, left ventricular ejection fraction. Methods
for LVEF measurements: o MUGA scan; ◊ Echocardiography using biplane
Simpson's method (performed by AHM).
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bances of the conduction system dramatically improved. The
LVEF increased to 41%, LBBB resolved and QRS duration
shortened to 94 ms. (Figs. 1 and 2) LV dimensions decreased;
LVEDD was 57 mm and 49 mm and LVESD 48 mm and
39 mm after six months and one year respectively. The
patient's condition remained stable for almost four years even
though during this time QRS duration began to increase again.
Four years after initial admission, movement of QRS frontal
plane from a normal axis to left axis deviation was observed
and LBBB returnedwith QRS duration of 146 ms followed by
a decline of LVEF. In the next four years MUGA and
echocardiograms showed progressive dilatation of LV. The
mid anteroseptal wall became akinetic, the basal septal wall
hypokinetic and impaired relaxation was observed together
with a reduction of LVEF, eventually being 34%. Four years
after the recurrence of LBBB the decisionwasmade to implant
a cardiac resynchronization device (CRT).Within twomonths
after implantation QRS decreased from 150 ms to 120 ms and
LVEF increased to 45%. Now, four years after CRT
implantation at an age of 62 years, LVEF and QRS duration
stabilized. LVEF is 55% and he has no complaints.Discussion
Collected ECG, echocardiography andMUGA data in our
case indicate that LBBB may have precipitated deterioration
of the LV function (Fig. 1). Progression of LV failure, four
years after the initiation of HF medication, was preceded by a
progressive increase in QRS duration together with the
change from normal QRS axis to left axis deviation. ECGs
before initial presentation are not present, but it is plausible thatinitially prolongation of QRS duration occurred, causing silent
onset of LBBB, which eventually led to HF with physical
complaints. It seems that in our case both medication and CRT
could resolve LBBB, along with a reduction in QRS duration
and re-establishment of LV synchrony, implying a relationship
between LBBB induced dyssynchrony and dilatation with
concomitant HF.
Blanc et al. reported that in some patients complete
normalization of LV function could be achieved after LV
resynchronization pacing in patients with non-ischemic
cardiomyopathy who had LBBB and severe HF. From these
results they speculate that LBBB-induced dyssynchrony leads
to a form of LV dysfunction, which aggravates intraventricular
conduction disturbances [3]. Vaillant et al. showed the
existence of a similar, specific LBBB-induced cardiomyopa-
thy resolved by CRT in 6 patients [4]. The Predictors of
Response to CRT–ECG substudy showed that narrowing of
the QRS duration after CRT predicted more LV volume
reduction, especially in patients with non-ischemic cardiomy-
opathy and LBBB [5].
The mechanisms of narrowing of QRS duration observed
after start of medication and later after initiation of CRT in the
present case are unclear. It may be due to either changes in the
specialized cardiac conduction system, or changes in intra-
myocardial impulse transmission. If the change is the result of
improved impulse transmission in the specialized conduction
tissue this could be the result of improved hemodynamics or
secondary to remodeling or perhaps even electrical regener-
ation of the conduction tissue. In a recent study byOgano et al.,
CRT restored ventricular septal myocardial perfusion and
enhanced ventricular remodeling in patients with non-ischemic
cardiomyopathy presenting with LBBB [6]. Similarly, more
efficient intramyocardial impulse transmission could possibly
result from improved hemodynamics or mechanical reverse
remodeling of the heart with smaller chamber sizes. Studies of
myocardial impulse transmissions in canine models of
dyssynchrony have shown changes in conduction velocity
and action potential duration, as well as distribution and
expression of connexins, also in the lateral wall of the LV
during LBBB [7]. Vernooy et al. demonstrated, in canine
hearts with long-term isolated LBBB, that biventricular pacing
could largely reverse the functional and structural abnormal-
ities induced by LBBB. This reversal occurred both globally
and regionally introducing the idea that dyssynchronopathy as
a result of LBBB can be “cured” by CRT [8]. The temporal
pattern and relationship that we describe is conjectural and it is
possible that another factor can be the driving force behind the
changes we observed.
This is, to our knowledge, the first case that describes
reversal of LBBB and the subsequent normalization of LV
function after 2 different therapies, first after start of HF
medication, and years later after implantation of a CRT
device. Usually LBBB is considered as a marker of
underlying structural cardiac disease. Fig. 1 suggests that
LBBB per semay result in the development of non-ischemic
cardiomyopathy due to permanent dyssynchronous activa-
tion of the LV. The idea of LBBB as a possible reversible
cause of non-ischemic cardiomyopathy warrants further
investigation.
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Fig. 2. Serial changes in the electrocardiogram leads I, aVL and V6. At initial presentation in June 2003 complete LBBB was present. However, after medication
LBBB resolved until in 2007 LBBB recurred which persisted until CRT implantation in 2011. *LBBB denotes left bundle branch block.
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